Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay

Nutrients. 2022 Dec 15;14(24):5323. doi: 10.3390/nu14245323.

Abstract

The intestinal microbiota represents the microbial community that colonizes the gastrointestinal tract and constitutes the most complex ecosystem present in nature. The main intestinal microbial phyla are Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria, Fusobacteria, and Verrucromicrobia, with a clear predominance of the two phyla Firmicutes and Bacteroidetes which account for about 90% of the intestinal phyla. Intestinal microbiota alteration, or dysbiosis, has been proven to be involved in the development of various syndromes, such as non-alcoholic fatty liver disease, Crohn's disease, and ulcerative colitis. The present review underlines the most recurrent changes in the intestinal microbiota of patients with NAFLD, Crohn's disease, and ulcerative colitis.

Keywords: Crohn’s disease; microbiota; non-alcoholic fatty liver disease; ulcerative colitis.

Publication types

  • Review

MeSH terms

  • Colitis, Ulcerative* / microbiology
  • Crohn Disease* / microbiology
  • Dysbiosis / microbiology
  • Firmicutes
  • Gastrointestinal Microbiome*
  • Humans
  • Inflammatory Bowel Diseases*
  • Microbiota*
  • Non-alcoholic Fatty Liver Disease* / microbiology

Grants and funding

This research received no external funding.